06/05/2025 7:30 AM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/04/2025 7:30 AM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2025 9:27 AM | HCW Biologics (Filer)
| Form 424B4 | |
05/14/2025 11:15 PM | HCW Biologics (Filer)
| Form EFFECT | |
05/13/2025 3:18 PM | HCW Biologics (Filer)
| Form S-1/A | |
05/09/2025 4:28 PM | Greene Rick S. (Reporting) HCW Biologics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2025 4:29 PM | Flowers Lee (Reporting) HCW Biologics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2025 4:30 PM | Byam Rebecca (Reporting) HCW Biologics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2025 4:31 PM | GARRETT SCOTT T (Reporting) HCW Biologics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2025 4:32 PM | HCW Biologics (Issuer) Wong Hing C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2025 4:33 PM | HCW Biologics (Issuer) Winer Gary M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for HCWB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for HCW Biologics and its competitors with MarketBeat's FREE daily newsletter.
|
05/09/2025 12:55 PM | HCW Biologics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
04/28/2025 8:17 AM | HCW Biologics (Filer)
| Form DEF 14A | |
04/28/2025 7:45 AM | HCW Biologics (Filer)
| Form DEFA14A | |
04/28/2025 7:50 AM | HCW Biologics (Filer)
| Form ARS | |
04/22/2025 4:15 PM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2025 11:15 PM | HCW Biologics (Filer)
| Form EFFECT | |
04/16/2025 3:26 PM | HCW Biologics (Filer)
| Form 424B3 | |
04/07/2025 5:06 AM | HCW Biologics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
04/01/2025 3:40 PM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2025 3:30 PM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2025 2:40 PM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2025 2:45 PM | HCW Biologics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/19/2025 4:00 PM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2025 6:00 AM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/21/2025 4:25 PM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/21/2025 4:29 PM | HCW Biologics (Filer)
| Form DEF 14A | |
02/11/2025 3:54 PM | HCW Biologics (Filer)
| Form PRE 14A | |
02/07/2025 3:45 PM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/03/2025 6:30 AM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/23/2024 7:30 AM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2024 3:37 PM | HCW Biologics (Filer)
| Form D Notice of Exempt Offering of Securities | |
11/22/2024 3:53 PM | HCW Biologics (Subject) Wong Hing C (Filed by)
| Form SC 13D/A | |
11/22/2024 3:45 PM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/20/2024 11:54 AM | HCW Biologics (Filer)
| Form 424B2 Transaction specifc information for a delayed shelf offering | |
11/18/2024 6:00 AM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2024 4:25 PM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/23/2024 3:35 PM | HCW Biologics (Filer)
| Form 8-K/A | |
08/14/2024 3:45 PM | HCW Biologics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024 3:40 PM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/12/2024 3:35 PM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
[No Brainer Gold Play]: “Show me a better investment.” (Ad) A Historic Gold Announcement Is About to Rock Wall Street?
For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains. Click here to get Garrett’s Top Four picks now. |
07/18/2024 6:00 AM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2024 3:30 PM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/17/2024 3:56 PM | HCW Biologics (Issuer) Winer Gary M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 3:57 PM | Greene Rick S. (Reporting) HCW Biologics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 3:33 PM | HCW Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |